Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 76 filings·Updated 30 Sept 2026
Showing 10 of 76 filings.
30 Sept 20261 filing
Company UpdateAcquisition

Mukka Proteins delays completion of Aqua Marine stake acquisition to January 2027

Acquisition overview

  • Target Aqua Marine, a partnership firm; line of business and country not disclosed.
  • Value up to Rs 15 crore for 51% stake via capital contribution.
  • Related party: promoter/group interests not disclosed.
  • Industry/sector: not disclosed.
  • Purpose: strategic investment via capital contribution; details not specified.
  • Regulatory approvals: not specified.
  • Timeline: originally 30 Sept 2026; revised to 31 Jan 2027.
  • Form of consideration: capital contribution.
  • Background: Aqua Marine's products/services not disclosed; incorporation date/turnover not provided.
Filed 12:36View Source
25 Sept 20261 filing
Insider Trading / SASTClosure of Trading Window

Mukka Proteins Limited: Trading window closed from 1 October 2026 till 48 hours after the declaration of financial results for the quarter and half year ending 30 September 2026

Mukka Proteins Limited: Trading window closed from 1 October 2026 till 48 hours after the declaration of financial results for the quarter and half year ending 30 September 2026

Filed 15:28View Source
24 Sept 20261 filing
Company UpdateAnalyst / Investor Meet

Mukka Proteins reschedules one-on-one investor meeting with Suraag Capital to Sept 29, 2026 (virtual)

Meeting Details

  • Original date: 28 September 2026; one-on-one virtual meeting with Suraag Capital.
  • Rescheduled to 29 September 2026; virtual meeting.

Participants

  • Key company participants: not disclosed in the filing.

Purpose

  • Purpose: investor interaction with analysts/institutional investors.

Additional Notes

  • Latest Investor Presentation available on the company's website.
Filed 17:15View Source
22 Sept 20261 filing
Company UpdateAnalyst / Investor Meet

Mukka Proteins to hold virtual one-on-one investor meeting with IFC on Sept 25, 2026

Meeting Details

  • Date: 25 September 2026; Virtual one-on-one meeting with IFC.
  • Organizer: International Finance Corporation (IFC).
  • Nature: One-on-one; Virtual meeting.

Participants

  • Company participants: management roles not disclosed in filing.

Purpose

  • Purpose: Analyst/institutional investor meeting.

Additional Notes

  • Copy of latest investor presentation available on the company website.
Filed 20:24View Source
12 Sept 20262 filings
Company UpdateAnalyst / Investor Meet

Mukka Proteins to hold virtual one-on-one investor meeting with ADD Capital on 17 September 2026

Meeting Details

  • Date: Thursday, 17 September 2026.
  • Mode: Virtual one-on-one meeting.
  • Organizer: ADD Capital.
  • Type: One-on-one investor meeting.
  • Time: not specified.

Participants

  • Company participants: Management representatives (roles not disclosed).

Purpose

  • Purpose: One-on-one investor meeting with ADD Capital.

Additional Notes

  • Latest investor presentation available on the company website.
Filed 15:11View Source
AGM/EGMAGM

Mukka Proteins 16th AGM: All resolutions approved, with multiple RPTs and key director appointments

AGM Details

  • AGM held on 10 September 2026 at 3:00 PM IST via video conference/AVM.
  • Shareholders cut-off date for voting: 3 September 2026.
  • Meeting conducted in compliance with Companies Act 2013 and MCA/SEBI circulars.

Key Resolutions

  • Resolution 1 (Ordinary): Adopt Audited Standalone and Consolidated Financial Statements.
  • Resolution 2 (Ordinary): Re-appoint Kalandan Mohammad Arif as Director.
  • Resolution 3 (Ordinary): Re-appoint Umaiyya Banu as Director.
  • Resolution 4 (Special): Increase borrowing limit under Companies Act 2013.
  • Resolution 5 (Special): Approve mortgage/charge on assets.
  • Resolution 6 (Special): Re-appoint Karkala Shankar Balachandra Rao as Non-Executive Independent Director.
  • Resolution 7 (Special): Re-appoint Hamad Bava as Non-Executive Independent Director.
  • Resolution 8 (Special): Re-appoint Narendra Surendra Kamath as Non-Executive Independent Director.
  • Resolution 9 (Special): Re-appoint Kalandan Mohammed Haris as MD and CEO.
  • Resolution 10 (Special): Re-appoint Kalandan Mohammed Althaf as Whole-Time Director and CFO.
  • Resolution 11 (Special): Re-appoint Kalandan Mohammad Arif as Whole-Time Director and COO.
  • Resolution 12 (Ordinary): Approve related party transactions with Atlantic Marine Products Private Limited.
  • Resolution 13 (Ordinary): Approve related party transactions with Progress Frozen and Fish Sterilization.
  • Resolution 14 (Ordinary): Approve related party transactions with Ullal Fish Meal and Oil Company.
  • Resolution 15 (Ordinary): Approve related party transactions with Mangalore Fish Meal and Oil Company.

Voting Results

  • All resolutions passed with requisite majority.
  • Related party votes on resolutions 12, 14, and 15 were invalidated; resolutions still passed.
  • Overall voting showed strong in-favour support (approximately 99.99% in favour across resolutions).

Director Changes

  • Kalandan Mohammad Arif re-appointed as Whole-Time Director and COO.
  • Umaiyya Banu re-appointed as Director.
  • Karkala Shankar Balachandra Rao appointed as Non-Executive Independent Director.
  • Hamad Bava appointed as Non-Executive Independent Director.
  • Narendra Surendra Kamath appointed as Non-Executive Independent Director.
  • Kalandan Mohammed Haris appointed as Managing Director and Chief Executive Officer.
  • Kalandan Mohammed Althaf appointed as Whole-Time Director and Chief Financial Officer.
  • Kalandan Mohammad Arif appointed as Whole-Time Director and Chief Operating Officer.

Auditor Appointments

  • No auditor appointment/rotation changes disclosed.
  • Financial statements approved with reports of existing Auditors.

Material Related Party Transactions

  • Approved related party transactions with Atlantic Marine Products Private Limited.
  • Approved related party transactions with Progress Frozen and Fish Sterilization.
  • Approved related party transactions with Ullal Fish Meal and Oil Company.
  • Approved related party transactions with Mangalore Fish Meal and Oil Company.

Other Material Approvals

  • Special resolutions approved for increased borrowing limit.
  • Special resolutions approved for creation of mortgage/charge on assets.
Filed 13:26View Source
10 Sept 20263 filings
Company UpdateGeneral

Mukka Proteins Ltd approves 5-year re-appointments of independent directors and C-suite executives for 2027–2032

Director and executive re-appointments

  • Re-appoints Karkala Shankar Balachandra Rao as Non-Executive Independent Director for 5-year term (2027–2032).
  • Re-appoints Hamad Bava as Non-Executive Independent Director for 5 years (2027–2032).
  • Re-appoints Narendra Surendra Kamath as Independent Director for 5-year term (2027–2032).
  • Re-appoints Kalandan Mohammed Haris as MD & CEO for 5 years (Jan 2027–Jan 2032).
  • Re-appoints Kalandan Mohammed Althaf as Whole-Time Director and CFO for 5 years (Jan 2027–Jan 2032).
  • Re-appoints Kalandan Mohammad Arif as Whole-Time Director and COO for 5 years (Jan 2027–Jan 2032).
  • Not debarred from holding office as director per SEBI/exchange circulars.
  • 16th AGM approved these re-appointments at its meeting on 10 September 2026.
Filed 22:44View Source
AGM/EGMAGM

Sixteenth AGM held via VC approves borrowing limits, RPTs, and director re-appointments.

AGM Details

  • Date and time: 10 September 2026, 3:00 PM IST.
  • Mode: VC/OAVM; conducted per MCA/SEBI circulars.
  • Duration: concluded at 4:26 PM IST.
  • Proxy not required due to virtual meeting.

Ordinary Resolutions

  • Adopt audited standalone and consolidated financial statements for the year.
  • Re-appoint director retiring by rotation.
  • Re-appoint another director retiring by rotation.

Special Resolutions

  • Special: Increase in overall borrowing limit under Companies Act.
  • Special: Approve mortgage/charge creation limit on assets.
  • Special: Re-appoint non-executive independent director.
  • Special: Re-appoint non-executive independent director (second).
  • Special: Re-appoint non-executive independent director (third).
  • Special: Re-appoint MD & CEO.
  • Special: Re-appoint WTD & CFO.
  • Special: Re-appoint WTD & COO.
  • Special: Approve related party transactions with entity A.
  • Special: Approve related party transactions with entity B.
  • Special: Approve related party transactions with entity C.
  • Special: Approve related party transactions with entity D.

Voting Status

  • Voting results to be declared after Scrutinizer's report.
  • Results to be uploaded on the company's website and with stock exchanges.
Filed 22:38View Source
Company UpdateAllotment of Securities

Mukka Proteins Allots 2 Crore Convertible Warrants on Preferential Basis

Warrant Allotment

  • Board approved allotment of 2,00,00,000 convertible warrants to non-promoter investors at Rs 23.50 each, totalling Rs 47 crore.
  • Upfront 25% subscription of Rs 5.88 per warrant received.
  • Each warrant is exercisable into one equity share on payment of 75% within 18 months; lock-in applies.
  • Annexures list 15 non-promoter allottees and respective warrant counts.
Filed 10:35View Source
1 Sept 20261 filing
Company UpdatePress Release / Media Release

Mukka Proteins outlines Bengaluru wet-waste bioconversion expansion to 1,000 TPD capacity

Operational capacity and milestones

  • Up to 1,000 TPD organic wet waste processing capacity at peak intake.
  • Current intake at 200 TPD; ramp to 400 TPD by March 27.
  • Further ramp to 1,000 TPD by December 27.
  • BSF bioconversion achieves about 80% mass reduction in 10-14 days.
  • Existing capacity: 291,720 MT/year across India and Oman.
  • FT1000 ranking: 311th in Asia-Pacific 2025 edition.
  • Exports to 25+ countries; strong global supply chain and export-grade certifications.
  • Insect protein meal >50% crude protein; oil rich in MCTs and lauric acid.
  • Waste diversion supports ESG goals with reduced methane emissions.
Filed 10:23View Source
Showing 10 of 76 filings